XSHE
000705
Market cap355mUSD
Oct 09, Last price
7.22CNY
1D
1.40%
1Q
16.08%
Jan 2017
-44.76%
Name
Zhejiang Zhenyuan Share Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Based in Shaoxing, China, Zhejiang Zhenyuan Share Co., Ltd. is a pharmaceutical entity with operations extending across China and into global markets. Established in 1752, the company provides a wide array of pharmaceutical offerings. These include various traditional Chinese medicines (such as patent medicines, raw materials, and herbal preparations), alongside modern chemical preparations, active pharmaceutical ingredients, biochemical compounds, anesthetics, psychotropic drugs, medical equipment, and chemical reagents. Its diverse product line is marketed under the Zhenyuan and Zhenyuantang brand names. The firm primarily caters to the pharmaceutical commerce and health service industries.
Key people
Haiming Wu
Executive Chairman of the Board · since 2025
Yufeng Zhang
Secretary of the Board · since 2025
Xiaochun Fu
Director · since 2023
Yuhua Lou
Deputy General Manager, Director · since 2024
Zhanyi Qian
Deputy General Manager, Director · since 2024
Hao Wang
Deputy General Manager, Staff Elected Director · since 2023
Min Wei
Deputy General Manager, Director · since 2022
Yuemei Zhou
Director · since 2020
Jian Feng
Independent Director · since 2023
Suhua Hu
Independent Director · since 2023
Hongwei Wang
Independent Director · since 2023
Jianwei Yuan
Independent Director · since 2023
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2020‑00 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | |||||||||||
Revenues | |||||||||||
Cost of revenue | |||||||||||
Unusual Expense (Income) | |||||||||||
NOPBT | |||||||||||
NOPBT Margin | |||||||||||
Operating Taxes | |||||||||||
Tax Rate | |||||||||||
NOPAT | |||||||||||
Net income | |||||||||||
Dividends | |||||||||||
Dividend yield | |||||||||||
Proceeds from repurchase of equity | |||||||||||
BB yield | |||||||||||
| Debt | |||||||||||
Debt current | |||||||||||
Long-term debt | |||||||||||
Deferred revenue | |||||||||||
Other long-term liabilities | |||||||||||
Net debt | |||||||||||
| Cash flow | |||||||||||
Cash from operating activities | |||||||||||
CAPEX | |||||||||||
Cash from investing activities | |||||||||||
Cash from financing activities | |||||||||||
FCF | |||||||||||
| Balance | |||||||||||
Cash | |||||||||||
Long term investments | |||||||||||
Excess cash | |||||||||||
Stockholders' equity | |||||||||||
Invested Capital | |||||||||||
ROIC | |||||||||||
ROCE | |||||||||||
| EV | |||||||||||
Common stock shares outstanding | |||||||||||
Price | |||||||||||
Market cap | |||||||||||
EV | |||||||||||
EBITDA | |||||||||||
EV/EBITDA | |||||||||||
Interest | |||||||||||
Interest/NOPBT | |||||||||||